Results 51 to 60 of about 18,022,149 (252)

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Molecular background of Rh D-positive, D-negative, D-el and weak D phenotypes in Chinese

open access: yes, 2002
Background and Objectives The aim of this study was to elucidate the genetic background of D-negative and D-el in the Chinese population. Materials and Methods We investigated nine D-positive, 76 D-negative, 26 D-el and three weak D Chinese individuals ...
Maas, J. H.   +9 more
core   +1 more source

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

Rescattering-induced $$D\rightarrow SS$$ D → S S weak decays

open access: yesEuropean Physical Journal C: Particles and Fields
We investigate two-body non-leptonic $$D\rightarrow SS$$ D → S S weak decays, where S denotes a light scalar meson such as $$a_0/a_0(980),$$ a 0 / a 0 ( 980 ) , $$f_0/f_0(980),$$ f 0 / f 0 ( 980 ) , or $$\sigma _0/f_0(500).$$ σ 0 / f 0 ( 500 ) .
Yan-Li Wang, Shu-Ting Cai, Yu-Kuo Hsiao
doaj   +1 more source

Investigating transcription factor dynamics in health and disease using FRAP

open access: yesFEBS Letters, EarlyView.
FRAP analysis of GFP‐tagged transcription factors reveals how molecular mobility and target engagement change in response to drug treatment. By combining live‐cell imaging, quantitative model fitting, and statistical analysis, this approach uncovers transcription factor dynamics linked to disease mechanisms, providing a powerful framework for ...
Kannan Govindaraj   +3 more
wiley   +1 more source

Bounds on weak and strong total domination in graphs

open access: yesElectronic Journal of Graph Theory and Applications, 2016
A set $D$ of vertices in a graph $G=(V,E)$ is a total dominatingset if every vertex of $G$ is adjacent to some vertex in $D$. Atotal dominating set $D$ of $G$ is said to be weak if everyvertex $v\in V-D$ is adjacent to a vertex $u\in D$ such that$d_{G}(v)
M.H. Akhbari, Nader Jafari Rad
doaj   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

open access: yesFEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta   +3 more
wiley   +1 more source

Weak D Testing is not Required for D? Patients With C?E? Phenotype

open access: yesAnnals of Laboratory Medicine, 2018
Although testing to detect weak D antigens using the antihuman globulin reagent is not required for D- patients in many countries, it is routinely performed in Korea. However, weak D testing can be omitted in D- patients with a C-E- phenotype as this indicates complete deletion of the RHD gene, except in rare cases. We designed a new algorithm for weak
Sooin Choi   +5 more
openaire   +2 more sources

The Hartman effect and weak measurements which are not really weak [PDF]

open access: yes, 2011
We show that in wave packet tunneling, localization of the transmitted particle amounts to a quantum measurement of the delay it experiences in the barrier.
E. Akhmatskaya   +5 more
core   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy